Donanemab was found to slow "clinical decline" by up to 35%, allowing people with the disease to continue performing day-to-day tasks such as shopping, housekeeping, managing their finances and taking medication.
Even if you could, would you want to double dip into your grandchildren’s savings and increase risk of ARIA (major risk of brain bleeds) all for a guarantee you’re going to die early and with dementia anyway?
PS: Grandiose claims like this warrant extra scrutiny.
Even if you could, would you want to double dip into your grandchildren’s savings and increase risk of ARIA (major risk of brain bleeds) all for a guarantee you’re going to die early and with dementia anyway? PS: Grandiose claims like this warrant extra scrutiny.